| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 35 |
| 1 | AFLIBERCEPT | 32 |
| 2 | BEVACIZUMAB | 25 |
| 3 | DEXAMETHASONE | 22 |
| 4 | ADALIMUMAB-AATY | 21 |
| 5 | ADALIMUMAB-ADAZ | 21 |
| 6 | ADALIMUMAB-FKJP | 21 |
| 7 | PENTOSAN POLYSULFATE SODIUM | 20 |
| 8 | RANIBIZUMAB | 20 |
| 9 | PREDNISONE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0227 |
| 1 | AFLIBERCEPT-AYYH | 1 | 0.0099 |
| 2 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0090 |
| 3 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 1 | 0.0081 |
| 4 | TETRACAINE HYDROCHLORIDE | 1 | 0.0075 |
| 5 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 6 | PEGCETACOPLAN | 9 | 0.0047 |
| 7 | PROPARACAINE HYDROCHLORIDE | 2 | 0.0037 |
| 8 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 4 | 0.0035 |
| 9 | OLUTASIDENIB | 1 | 0.0035 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 53 |
| 1 | Corticosteroid [EPC] | 51 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 28 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 18 |
| 5 | GLP-1 Receptor Agonist [EPC] | 14 |
| 6 | Calcium [EPC] | 13 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 8 | Insulin Analog [EPC] | 13 |
| 9 | Provitamin D2 Compound [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Volume Expander [EPC] | 3 | 0.0010 |
| 1 | Antiseptic [EPC] | 4 | 0.0009 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 3 | 0.0007 |
| 3 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 4 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 5 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 6 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 7 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 53 | 0.0003 |